Search PDMR transactions

Notifier
Name
TORBJÖRN WÄRNHEIM
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
TORBJÖRN WÄRNHEIM
Position
Director Pharmaceutical Innovation Development
Initial notification
Yes
Amendment
No
Details of amendment
Issuer
Name of issuer
Moberg Pharma AB (publ)
LEI code
549300XFXK7DVGDRP410
Details of transaction
Financial instrument ISIN code Nature of transaction Linked to a share option programme Volume Unit Price Currency code Transaction date Trading venue
Moberg Pharma AB SE0003613090 Acquisition 1,500 Quantity 23.90 SEK 09/03/2018 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Trading venue Volume Weighted average price
Moberg Pharma AB SE0003613090 Acquisition 09/03/2018 NASDAQ STOCKHOLM AB 1,500 (Quantity) 23.90 SEK
<< Back